Cleo is a London-headquartered conversational AI personal-finance app founded in 2016 by Barney Hussey-Yeo and Alessandro Isaja. The product, marketed primarily in the United States, combines an AI chat assistant with budgeting, savings, and short-term cash advance features that compete with apps such as Dave and Earnin.
Cleo serves more than 5 million users, the majority in the US, and reached approximately $90 million in annualised revenue by 2023. The principal UK entity, Cleo AI Ltd., is a private limited company registered at Companies House.
The company has raised more than $130 million across rounds led by EQT Ventures, Sofina, Balderton Capital, and Bond, with its Series C closing in 2022 at a reported valuation of around $500 million.
Cleo's commercial model relies on subscription revenue and partnership economics with US bank partners that issue the underlying cash-advance products, while the UK Ltd handles intellectual property, engineering, and corporate functions.
The company is one of a small group of UK-built, US-revenue fintechs that demonstrates how a London-incorporated company can scale internationally without restructuring under a US top-co.
Cleo is a useful UK case study because the company has built almost all of its commercial revenue in the United States while keeping its corporate structure firmly inside England and Wales. The principal UK entity, Cleo AI Ltd., remains an English Ltd registered at Companies House, sitting above US operating subsidiaries that hold state-by-state lending and money-transmitter relationships.
This UK-Ltd-with-US-subsidiaries pattern is more common than a Delaware top-co flip among UK fintechs because it preserves access to UK R&D tax credits (which are generous and based on the UK SME or RDEC regimes), keeps the founders within the UK SEIS/EIS-eligible investor pool at early stages, and avoids the tax cost of a future inversion if the company eventually lists in London or is acquired by a UK buyer.
Each successive Cleo round has been filed at Companies House as an updated statement of capital with new preferred-share classes, anti-dilution provisions, and persons-with-significant-control updates.
The company has not pursued an IPO, and if it did, the strategic question would mirror Wise's 2021 dilemma: list on the LSE Main Market under the new 2024 unified segment that permits dual-class structures, list on AIM (unlikely given scale and revenue), or pursue a US listing via Delaware inversion.
The latter would be tax-expensive given accumulated UK IP value but would access deeper investor pools and higher revenue multiples typical of US consumer-fintech listings.
Cleo's structure is also instructive on EMI options: as the company has grown beyond the GBP 30 million gross-asset and 250-employee EMI limits, more recent grants have shifted to non-tax-advantaged unapproved options, a transition every successful UK Ltd eventually navigates.
Cleo AI Ltd. is a private limited company incorporated in England and Wales and registered at Companies House, with its head office in Shoreditch, London.
Cleo is not currently FCA-authorised because the product is offered to US customers through US bank-partner arrangements rather than as a UK regulated financial service.
No. Cleo retains a UK Ltd as the top-level operating entity, with US subsidiaries underneath. This structure preserves access to UK R&D tax credits and avoids the tax cost of an inversion.
Cleo has not announced a listing. Possible future routes include the LSE Main Market under the 2024 listing reforms, a US listing via Delaware inversion, or continued private growth.
